Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy
Stroke - United States
doi 10.1161/strokeaha.112.653329
Full Text
Open PDFAbstract
Available in full text
Date
September 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)